Insomnia features and patient-reported daytime sleepiness in patients with obstructive sleep apnea
Sleep Medicine · 2025
DOI: 10.1016/j.sleep.2025.02.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep Medicine, 2025. Verfasst von H Gouveris und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sleep Medicine and Neurostimulation Center & Department of Otorhinolaryngology, University Medical Center Mainz, Mainz, Germany. Electronic address: …. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Sleep Initiation and Maintenance Disorders, Disorders of Excessive Somnolence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Earth and Space Sciences, College of the Environment, University of Washington.
Themen: Schlaf
Abstract (Originalsprache)
Previous preliminary evidence suggests insomnia features playing a major causative or confounding role in daytime sleepiness in obstructive sleep apnea (OSA) patients. We investigated further this hypothesis in a larger OSA patient cohort. In a cross-sectional study in a tertiary medical center, consecutive patients presenting with suspected OSA, but without other sleepiness-promoting comorbidities, and tested by in-lab polysomnography (PSG) were evaluated prospectively for excessive daytime sleepiness (EDS) using the Epworth Sleepiness Scale (ESS) and for insomnia using the Insomnia Severity Index (ISI) respectively. Two hundred and thirty patients (63 female; average age: 54,1 y) were included in this OSA treatment-naïve cohort. ISI values correlated best (Spearman's rho = 0,29, p < .001) with the total ESS score than any PSG -associated metric did. Especially ISI item 7- (interference of sleep problems with daily functions, r = 0,33, p < .001) and item 2 - (difficulty staying asleep, r = 0,28, p < .001) and to a lesser degree item 4 - (satisfaction with own current sleep patterns, r = 0,23, p = 0,025) scores showed significant correlations. Notably, no single significant correlation was found between ESS score and any PSG-metric at all. In a multiple regression analysis, the ISI item 7 score emerged as the sole significant independent predictor of the ESS score. We conclude that insomnia may significantly impact patient-reported daytime sleepiness in OSA patients. We suggest that assessment of insomnia symptoms and features (e.g. by means of ISI) should always be performed in OSA patients reporting daytime sleepiness. We propose that these preliminary findings should be validated in larger and diverse cohorts of OSA patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Sleep Medicine and Neurostimulation Center & Department of Otorhinolaryngology, University Medical Center Mainz, Mainz, Germany. Electronic address: haralampos.gouveris@unimedizin-mainz.de.
- Sleep Medicine and Neurostimulation Center & Department of Otorhinolaryngology, University Medical Center Mainz, Mainz, Germany.
- Department of Sports Medicine, Rehabilitation and Disease Prevention, University of Mainz, Mainz, Germany.
Förderung
- Department of Earth and Space Sciences, College of the Environment, University of Washington
Zitieren
APA
Gouveris, H., Deiß, A., Hackenberg, B., Bahr-Hamm, K., Huppertz, T., Ludwig, K., Matthias, C., & Simon, P. (2025). Insomnia features and patient-reported daytime sleepiness in patients with obstructive sleep apnea. Sleep Medicine. https://doi.org/10.1016/j.sleep.2025.02.035
Vancouver
Gouveris H, Deiß A, Hackenberg B, Bahr-Hamm K, Huppertz T, Ludwig K, et al. Insomnia features and patient-reported daytime sleepiness in patients with obstructive sleep apnea. Sleep Medicine. 2025. doi:10.1016/j.sleep.2025.02.035
BibTeX
@article{Gouveris2025,
author = {Gouveris, H and Deiß, A and Hackenberg, B and Bahr-Hamm, K and Huppertz, T and Ludwig, K and Matthias, C and Simon, P},
title = {Insomnia features and patient-reported daytime sleepiness in patients with obstructive sleep apnea},
journal = {Sleep Medicine},
year = {2025},
doi = {10.1016/j.sleep.2025.02.035}
}
EUVIMED